Su et al. observed that the treatment with a histone deacetylases inhibitor, in mice with an induced cerebral ischemia, increases the expression of zo-1, OCLN, and CLN5 in the brain endothelial cells, that improves the blood-brain barrier integrity [48]. This evidence concerns the gene CLN5 and Cerebral ischemia.